Enovis (ENOV) Other Working Capital Changes (2010 - 2011)
Enovis' (ENOV) quarterly Other Working Capital Changes came in at $14.2 million in Q2 2026, up 249.03% year-on-year from $4.1 million in Q2 2025, and up 162.49% on a QoQ basis from -$22.7 million in Q4 2025.
Enovis (ENOV) Other Working Capital Changes (2010 - 2011) Analysis & Trends
Enovis (ENOV) has 17 years of Other Working Capital Changes data on file, last reported at $14.2 million in Q2 2026.
- On a quarterly basis, Other Working Capital Changes rose 249.03% year-over-year to $14.2 million in Q2 2026; TTM through Apr 2026 was -$15.6 million, a 37.47% increase from a year earlier, with the FY2025 full-year figure at -$39.3 million, down 496.08% from the prior year.
- Other Working Capital Changes for Q2 2026 stood at $14.2 million, up from -$22.7 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for ENOV reached as high as $1.4 million in Q4 2010 and fell as low as -$2.6 million in Q4 2011.
- Historically, Other Working Capital Changes has averaged $635941.2 across 5 years, with a median of $2.2 million in 2023.
- Across the five-year window, Other Working Capital Changes soared 658.19% in 2024 and tumbled 2826.84% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$6.0 million in 2022, then tumbled by 269.31% to -$22.1 million in 2023, then jumped by 96.5% to -$775000.0 in 2024, then tumbled by 2826.84% to -$22.7 million in 2025, then soared by 162.49% to $14.2 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $14.2 million in Q2 2026, -$22.7 million in Q4 2025, and $15.5 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -2.60 Mn |
| Dec 31, 2011 | -2.60 Mn |
| Dec 31, 2011 | -2.60 Mn |
| Sep 30, 2011 | 778,000.00 |
| Sep 30, 2011 | 778,000.00 |
| Sep 30, 2011 | 778,000.00 |
| Dec 31, 2010 | 1.44 Mn |
| Dec 31, 2010 | 1.44 Mn |
| Dec 31, 2010 | 1.44 Mn |
| Oct 1, 2010 | -1.59 Mn |
| Oct 1, 2010 | -1.59 Mn |
| Oct 1, 2010 | -1.59 Mn |